Rubin Lab


AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary.
Rubin DT, Feuerstein JD, Wang AY, Cohen RD. Gastroenterology. 2020. 159(1):350-357.

SARS-CoV-2 Vaccination for Patients with Inflammatory Bowel Diseases: Recommendations from an International Consensus Meeting
Siegel CA, Melmed GY, McGovern DPB, Rai V, Kramer DT, Rubin DT, Abreu MT, Dubinsky MC. Gut. 2021;70(4):635-640.

Management of Patients with Crohn’s Disease and Ulcerative Colitis During the COVID-19 Pandemic: Results of an International Meeting.
Rubin DT, Abreu MT, Rai V, Siegel CA. Gastroenterology. 2020. 159(1):6-13.

Winter is coming! Clinical, immunological, and practical considerations for vaccinating patients with IBD during the COVID pandemic.
Melmed GY, Rubin DT, McGovern DPB. Gastroenterology. 2021;160(3):639-644.

Review Article: Prevention, Diagnosis and Management of COVID-19 in the IBD Patient.
Al-Ani AH, Prentice RE, Rentsch CA, Johnson D, Ardalan Z, Heerasing N, Garg M, Campbell S, Sasadeusz J, Macrae FA, Ng SC, Rubin DT, Christensen B. Aliment Pharmacol Ther. 2020;52(1):54-72.

Management of Acute Severe Ulcerative Colitis in a Pregnant Woman with COVID-19 Infection: A Case Report and Review of Literature.
Rosen MD, Axelrad J, Hudesman D, Rubin DT, Chang S. Inflamm Bowel Dis. 2020;26(7):971-973.

Temporal Improvement of COVID-19 Positive Crohn’s Disease Patients Treated with Bismuth Subsalicylate.
Wolf DC, Wolf CH, Rubin DT. Am J Gastroenterol. 2020;115(8):1298.

Care of the Patient with IBD Requiring Hospitalization During the COVID-19 Pandemic. 
Allez M, Fleshner P, Gearry R, Lakatos PL, Rubin DT. J Crohns Colitis. 2020;14(Supplement_3):S774-S779.

Practical advice for management of inflammatory bowel disease patients during the COVID-19 pandemic: World Endoscopy Organization Statement.
Neumann H, Emura F, Bokemeyer B, Guda N, Tajiri H, Matsumoto T, Rubin DT. Dig Endosc. 2020;32(5):658-662.

COVID-19 and Inflammatory Bowel Disease: Lessons Learned, Practical Recommendations, and Unanswered Questions.
Ungaro RC, Kappelman MD, Rubin DT, Colombel JF. Gastroenterology. 2021;160(5):1447-1451.

Worldwide management of inflammatory bowel disease during the COVID-19 pandemic: An international survey.
Bernstein CN, Ng SC, Banerjee R, Steinwurz F, Shen B, Carbonnel F, Hamid S, Sood A, Yamamoto-Furusho JK, Griffiths A, Benchimol EI, Travis S, Lopes S, Rubin DT, Kaplan GG, Armstrong D, Gearry R. Inflamm Bowel Dis. 2020. [Epub ahead of print August 14 2020].

Coronavirus and Patients with Inflammatory Bowel Disease: Management Strategies for The Practicing Clinician.
Lichtenstein GR, Rubin DT. Am J Gastroenterol. 2020;115(10):1566-1569.

Optimal Inflammatory Bowel Disease Management During the Global COVID-19 Pandemic.
El Ouali S, Rubin DT, Cohen BL, Regueiro MD, Rieder F. Curr Opin Gastroenterol. 2021. [Epub ahead of print April 14 2021]. PMID: 33859104.

Stopping Clinical Trials in Inflammatory Bowel Disease During the COVID-19 Pandemic is not a Responsible Act.
Schreiber S, Dignass A, Rogge A, Rubin DT. J Crohns Colitis. 2020. [Epub ahead of print June 25 2020]. PMID: 32582946.

Expert Comment: The Clinical Challenges of Digestive Manifestations of COVID-19.
Rubin DT, Ayoub FW. Practice Update [Online].

Fecal Microbiota Transplantation for Recurrent C difficile Infection During the COVID-19 Pandemic: Experience & Recommendations.
Khanna D, Tande A, Rubin DT, Khoruts A, Kahn SA, Pardi D. Mayo Clin Proc. 2021. [In Press].